The American Vision Partners-affiliated practice said April 12 that Dr. Perkins participated in the FDA clinical trials for the implant. The lens, which is produced by Staar Surgical, is used to treat nearsightedness and astigmatism.
“Over one million EVO lenses have already been implanted by doctors outside the U.S., and 99.4 percent of EVO patients in a survey have stated they would have the procedure again,” Staar Surgical President and CEO Caren Mason said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
